• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Northwest Biotherapeutics Inc

+ Add to Watchlist

NWBO:US

5.0300 USD 0.1800 3.45%

As of 20:10:00 ET on 09/30/2014.

Snapshot for Northwest Biotherapeutics Inc (NWBO)

Open: 5.2200 Day's Range: 5.0000 - 5.2200 Volume: 462,162
Previous Close: 5.2100 52wk Range: 3.1000 - 10.6400 1-Yr Rtn: +49.26%

Stock Chart for NWBO

No chart data available.
  • NWBO:US 5.0550
  • 1D
  • 1M
  • 1Y
5.2100
Interactive NWBO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NWBO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.1408
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 299.31
Shares Outstanding (M) 59.51
30 Day Average Volume 428,401
Price/Book (mrq) -
Price/Sale (ttm) 443.5831
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NWBO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NWBO

Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.

Linda F PowersChairman/President/CEOMarnix L BoschChief Technology Officer
Alton L BoyntonChief Scientific OfficerAnthony E Maida IIISenior VP:Clinical Research
More Company Profile & Key Executives for NWBO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil